Larvol Delta - BDTX1535101-Phase-12-Study-of-Silevertinib-BDTX1535-in-Patients-With-Glioblastoma-or-NonSmall-Cell-Lung-Cancer-With-EGFR-Mutations

Tagrisso (osimertinib) - AstraZeneca

BDTX-1535 - Black Diamond Therap

http://clinicaltrials.gov/ct2/show/NCT05256290

Jul 11, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next